Claros Technologies has announced the raising of $55 million in funding to scale up commercial use and develop solutions for PFAS remediation. These funds will be directed towards expanding production capacities, improving operational efficiency, and advancing the company's PFAS destruction technology across North America, Europe, and Asia, as well as supporting further research and development.
Funding Round Leaders
The funding round was led by Treehouse Family Capital LLC in partnership with Daikin America, with participation from Veralto, Bush Foundation, Nord Asset Management, Saint Paul & Minnesota Foundation, and existing investors. This announcement enables Claros Technology to execute its next global growth strategies.
Expanding Commercial Application
The company also plans to grow ClarosLabs, its analytical services division, as various industries require reliable testing and permanent PFAS destruction methods. Claros positions itself as a provider of comprehensive solutions for mitigating PFAS contamination.
The ClarosTechUV system provides permanent destruction of PFAS compounds—both long-chain, short-chain, and ultra-short-chain—by completely eliminating contaminants rather than merely transferring them between waste streams. Today, this technology is utilized by industrial manufacturers, environmental remediation firms, consulting companies, utilities, and government agencies worldwide. The raised capital will significantly boost engineering and manufacturing operations while accelerating the adoption of the technology in the global market among industrial clients.
Team Development and Customer Support
ClarosTech also intends to increase hiring in both commercial and technical teams, as well as strengthen customer support capabilities. The company will continue to invest in developing applications to meet growing customer demand and ensure global commercial deployment.
Transitioning to Commercial Success
CEO and co-founder Michelle Belanca noted that ClarosTech has transitioned from the technology validation stage to commercial success. She explained that successful industrial and environmental projects have demonstrated the platform's effectiveness at a large scale.
Regulation and Environmental Requirements
The demand for permanent PFAS destruction is rising amid tightening environmental standards from governments. Earlier this year, the technology showed similar results in large-scale groundwater restoration projects. European regulators continue to push restrictions under the proposed REACH framework, while US federal and state agencies are expanding rules for drinking water, industrial discharge requirements, and remediation programs.
Claros believes that organizations now require both reliable destruction technology and precise laboratory analysis to meet compliance obligations. In addition to its destruction platform, ClarosLabs offers accredited detection, quantification, and impact assessment services for PFAS.
Investor Achievements and Confidence
The company highlighted several recent achievements that have strengthened investor confidence. At the end of 2025, Claros partnered with Daikin America to complete one of the world's largest industrial PFAS destruction demonstrations, achieving over 99.99% destruction of target PFAS compounds.
This latest funding reflects growing confidence in environmental technologies that combine scientific innovation with commercial scalability. Investors believe that Claros has reached a critical stage where its focus is shifting from technology validation to broad implementation across various industries.
Prospects and Technology Applications
Treehouse Family Capital Manager Jack Kogen stated that Claros has proven that its integrated destruction and analysis platform works effectively in real-world conditions. The company is ideally positioned to capitalize on a strong regulatory trend and meet the global market's desire for permanent PFAS solutions. Founded in 2018 in Minneapolis, Claros develops technologies for the irreversible elimination of PFAS for sectors such as semiconductor manufacturing, aerospace, pharmaceuticals, and healthcare, which need to find alternative ways to manage these chemicals in the future.